glp 1 sales GLP-1 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 Pharma Giants Bet on Next-Generation

Eli Lilly has announced plans to begin Phase 3 trials by the end of 2026

Medications like Semaglutide GLP-1, which mimic the natural GLP-1 hormone , are used as effective treatments for weight loss when combined with healthy lifestyle changes, nutrition, and exercise

The formulation used in the study (conjugated equine estrogens combined with medroxyprogesterone acetate) isn't the same as the bioidentical formulations that have become standard in contemporary practice

However, many insurance companies do not cover weight loss medications such as Wegovy and Zepbound when used solely for weight reduction

The 12mg dose reduced systolic blood pressure by an average of 14.0 mmHg

doi: 10.1016/s0006-2952(02)01212-1